SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.
SyntheX's investors include 8VC, Bristol-Myers Squibb, SOSV, SOSV SF & NY (Fka IndieBio), Oriza Ventures.
SyntheX is headquartered in San Francisco, United States.
SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.
SyntheX is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SyntheX — Funding & Investors." VCBacked, May 23, 2025, https://www.vcbacked.co/company/synthex. Accessed July 19, 2026.
VCBacked. (2025). SyntheX — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/synthex
{{cite web |title=SyntheX — Funding & Investors |url=https://www.vcbacked.co/company/synthex |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated